精细运动的锥体外系调节：抗精神病药物基本治疗作用的“必要条件” - Suppr

Suppr

超能文献

Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs.

作者信息

HAASE H J

出版信息

Rev Can Biol. 1961 Jun;20:425-49.

PMID:13903363

Abstract

摘要

相似文献

Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs.

Rev Can Biol. 1961 Jun;20:425-49.

Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. I. Treatment with trifluoperazine singly and in combination with trihexyphenidyl.

Compr Psychiatry. 1962 Aug;3:227-34.

The purely neuroleptic effects and its relation to the "neuroleptic threshold".

Acta Psychiatr Belg. 1978 Jan-Feb;78(1):19-36.

A parallel between the profile of clinical activity and the character of extrapyramidal activity of neuroleptics.

Rev Can Biol. 1961 Jun;20:575-7.

Phenothiazine ataraxics. Extrapyramidal reactions.

Calif Med. 1960 Jul;93(1):24-8.

[THE INFLUENCE OF ACTION OF ANTINEUROLEPTIC DRUGS ON THE NEUROLEPTIC THRESHOLD].

Int J Neuropsychiatry. 1965 May-Jun;1:239-52.

Carphenazine and the extrapyramidal regulation of kinesthetic function.

Dis Nerv Syst. 1962 Jun;23:340-8.

The implications of extrapyramidal symptoms in the treatment of schizophrenia.

Rev Can Biol. 1961 Jun;20:545-8.

The relationship of drug-induced neurological phenomena on therapeutic outcome.

Rev Can Biol. 1961 Jun;20:579-82.

Some comments on the psychodynamic aspects of the extrapyramidal reactions.

Rev Can Biol. 1961 Jun;20:623-9.

引用本文的文献

The development of antipsychotic drugs.

Brain Neurosci Adv. 2018 Dec 5;2:2398212818817498. doi: 10.1177/2398212818817498. eCollection 2018 Jan-Dec.

Increasing antipsychotic dose for non response in schizophrenia.

Cochrane Database Syst Rev. 2018 May 11;5(5):CD011883. doi: 10.1002/14651858.CD011883.pub2.

Clozapine for severe ("kraepelinian") schizophrenia: Sustained improvement over 5 years.

Dement Neuropsychol. 2008 Jan-Mar;2(1):71-75. doi: 10.1590/S1980-57642009DN20100014.

A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia.

J Clin Psychopharmacol. 2015 Apr;35(2):168-74. doi: 10.1097/JCP.0000000000000277.

Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Psychiatry Res. 2010 May 15;177(1-2):77-83. doi: 10.1016/j.psychres.2009.07.005. Epub 2010 Apr 9.

Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone.

Hum Mov Sci. 2009 Oct;28(5):633-42. doi: 10.1016/j.humov.2009.07.007. Epub 2009 Aug 18.

Dose response and atypical antipsychotics in schizophrenia.

CNS Drugs. 2004;18(9):597-616. doi: 10.2165/00023210-200418090-00005.

Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies.

CNS Drugs. 2001;15(9):671-8. doi: 10.2165/00023210-200115090-00001.

Managing antipsychotic-induced parkinsonism.

Drug Saf. 1999 Mar;20(3):269-75. doi: 10.2165/00002018-199920030-00006.

Clozapine plasma level monitoring: current status.

Psychiatr Q. 1996 Winter;67(4):297-311. doi: 10.1007/BF02326373.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验